Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
To cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026 and Sep 2026.
- Largest single sale: $174K (4,503 shares) of Teva Pharmaceutical Industries Ltd on Sep 18, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd (TEVA) | Interim Chief Legal Officer | Feb 23, 2026 | Sep 22, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 18, 2026, Teva Pharmaceutical Industries Ltd: sold 7,342 shares for $285K, no plan disclosed; 4,503 shares acquired by exercising options. 1 filing: 1
- Mar 5, 2026, Teva Pharmaceutical Industries Ltd: sold 1,127 shares for $36K, to cover taxes; 3,580 shares vested. 1 filing: 1
- Mar 4, 2026, Teva Pharmaceutical Industries Ltd: sold 2,675 shares for $87K, to cover taxes; 4,744 shares vested; 3,466 shares vested or acquired by exercising options. 1 filing: 1
- Mar 3, 2026, Teva Pharmaceutical Industries Ltd: sold 1,274 shares for $41K, to cover taxes; 3,461 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.